Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 2 |
2012 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway.
Clin Cancer Res. 2011 May 15;17(10):3204-18. doi: 10.1158/1078-0432.CCR-10-2451. Epub 2011 Apr 1.
Clin Cancer Res. 2011.
PMID: 21459798
Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis.
Unterkircher T, Cristofanon S, Vellanki SH, Nonnenmacher L, Karpel-Massler G, Wirtz CR, Debatin KM, Fulda S.
Unterkircher T, et al.
Clin Cancer Res. 2011 Jun 15;17(12):4019-30. doi: 10.1158/1078-0432.CCR-11-0075. Epub 2011 Apr 27.
Clin Cancer Res. 2011.
PMID: 21525171
Item in Clipboard
Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, Häcker S, Vellanki SH, Lausen J, Debatin KM, Fulda S.
Bangert A, et al.
Oncogene. 2012 Nov 1;31(44):4677-88. doi: 10.1038/onc.2011.614. Epub 2012 Jan 23.
Oncogene. 2012.
PMID: 22266862
Item in Clipboard
Cite
Cite